The Online Investor
EBS Buyback image

Emergent BioSolutions Inc. Buyback

OLI recorded this information on 11/11/2021

Company: Emergent BioSolutions Inc.
Buyback: EBS buyback
$Amount Authorized: $250,000,000
Buyback Details: Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized management to repurchase up to $250 million of the company's common stock from time to time on the open market or in privately negotiated transactions. This repurchase authorization expires on November 11, 2022.

Emergent BioSolutions is a life sciences company focused on providing a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). Co. is focused on products and solutions that address the following five distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives; emerging infectious diseases; travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). Co. has a product portfolio of ten marketed products (vaccines, therapeutics, and drug-device combination products).

EBS SEC Filing Email Alerts Service

Open the EBS Page at The Online Investor »

Company Name: 
Emergent BioSolutions Inc
Stock buyback: 
EBS buyback
Website: 
www.emergentbiosolutions.com
Sector: 
Biotechnology
Number of ETFs Holding EBS: 
59
Total Market Value Held by ETFs: 
$448.99M
Total Market Capitalization: 
$1.63B
% of Market Cap. Held by ETFs: 
27.51%
 

Open the EBS Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree EBS Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (2.80 out of 4)
9th percentile
(ranked lower than approx. 91% of all stocks covered)

Analysts' Target Price:
EBS Stock Forecast

Based on Zacks ABR data;
powered by Xignite

EBS Buyback Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.